Abstract
Post Hoc Analysis of Responses to Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) By Baseline BCR-ABL1 Level and Baseline Mutation Status in the Optic Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have